China Isotope & Radiation Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
China Isotope & Radiation şirketinin toplam hissedar öz sermayesi CN¥7.3B ve toplam borcu CN¥2.0B olup, bu da borç-öz sermaye oranını 27.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥13.7B ve CN¥6.4B dir. China Isotope & Radiation 'in FAVÖK'ü CN¥820.4M faiz karşılama oranı 163.9 dur. Şirketin CN¥3.0B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
27.4%
Borç/özkaynak oranı
CN¥2.01b
Borç
Faiz karşılama oranı | 163.9x |
Nakit | CN¥3.01b |
Eşitlik | CN¥7.33b |
Toplam yükümlülükler | CN¥6.42b |
Toplam varlıklar | CN¥13.74b |
Son finansal sağlık güncellemeleri
China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Recent updates
China Isotope & Radiation Corporation's (HKG:1763) 36% Share Price Surge Not Quite Adding Up
Oct 07China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think
May 05Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price
Apr 26China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
May 13Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Feb 07China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends
Dec 20A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)
Oct 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
Aug 30Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?
Jun 10China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?
Dec 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal
Oct 08Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?
Sep 05Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture
Jun 13When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?
May 24China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)
Mar 14The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More
Feb 04Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Jan 09Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 1763 'nin kısa vadeli varlıkları ( CN¥8.5B ) kısa vadeli yükümlülüklerini ( CN¥4.4B ) aşıyor.
Uzun Vadeli Yükümlülükler: 1763 şirketinin kısa vadeli varlıkları ( CN¥8.5B ) uzun vadeli yükümlülüklerini ( CN¥2.0B ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 1763 şirketinin toplam borcundan daha fazla nakiti var.
Borcun Azaltılması: 1763 şirketinin borç/öz sermaye oranı son 5 yılda 5.6% seviyesinden 27.4% seviyesine yükseldi.
Borç Kapsamı: 1763 'nin borcu işletme nakit akışı ( 12.9% ) tarafından iyi bir şekilde karşılanmıyor.
Faiz Kapsamı: 1763 'in borcuna ilişkin faiz ödemeleri EBIT ( 163.9 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.